Increasing neurofilament light chain and glial fibrillary acidic protein levels, but not change in the amyloid-β42/40 ratio or phosphorylated tau 181, were associated with worsening cognitive function and incident cognitive impairment. This evidence concerns the gene MAPT and Cognitive impairment.